PMA supplement
P810031 S065: Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)
FDA PMA supplement · Normal 180 Day Track · Johnson & Johnson Surgical Vision, Inc.
Key facts
| Original PMA | P810031 |
|---|---|
| Supplement number | S065 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD) |
| Generic name | AID, SURGICAL, VISCOELASTIC |
| Applicant | Johnson & Johnson Surgical Vision, Inc. |
| Product code | LZP |
| Received date | Dec 3, 2018 |
| Decision date | Apr 29, 2019 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: